Market revenue in 2023 | USD 198.4 million |
Market revenue in 2030 | USD 321.6 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.57% in 2023. Horizon Databook has segmented the UK implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
According to British Heart Foundation, more than 30,000 out-of-hospital cardiac arrests are reported each year in the UK. The survival rate is very low, accounting for less than 1 in every 10 cases surviving the arrest.
Furthermore, as per the NHS, more than 2 million people in the country suffer from arrhythmias and, 1 in every 250 people suffers from cardiomyopathy. Therefore, significant market opportunity for ICD exists in the region.
Moreover, as per a report from MedTech Europe, an estimated 85 units/million population in the U.K. underwent biventricular device implantation in 2019. Moreover, a significant correlation between high blood pressure & its negative effect on LVH is expected to drive the market for ICD in the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the UK implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into UK implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account